ES2110098T3 - Procedimiento de produccion de formulaciones para medicamentos. - Google Patents

Procedimiento de produccion de formulaciones para medicamentos.

Info

Publication number
ES2110098T3
ES2110098T3 ES93914852T ES93914852T ES2110098T3 ES 2110098 T3 ES2110098 T3 ES 2110098T3 ES 93914852 T ES93914852 T ES 93914852T ES 93914852 T ES93914852 T ES 93914852T ES 2110098 T3 ES2110098 T3 ES 2110098T3
Authority
ES
Spain
Prior art keywords
mold
production procedure
drug formulations
disclosed
longitudinal axis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93914852T
Other languages
English (en)
Inventor
David John Livesley
Ian Michael Daines Gaylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of ES2110098T3 publication Critical patent/ES2110098T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B15/00Details of, or accessories for, presses; Auxiliary measures in connection with pressing
    • B30B15/02Dies; Inserts therefor; Mounting thereof; Moulds
    • B30B15/022Moulds for compacting material in powder, granular of pasta form
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B11/00Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B11/00Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/007Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a plurality of pressing members working in different directions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/02Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • A61M2202/066Powder made from a compacted product by abrading
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S425/00Plastic article or earthenware shaping or treating: apparatus
    • Y10S425/014Expansible and collapsible
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S425/00Plastic article or earthenware shaping or treating: apparatus
    • Y10S425/044Rubber mold

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA PRODUCCION DE CUERPOS COMPACTADOS DE MEDICAMENTOS EN POLVO, COMPRENDIENDO DICHO PROCESO LOS PASOS DE: A) POSICIONADO DE ELEMENTOS EXPANSIBLES A LO LARGO DEL EJE LONGITUDINAL DEL MOLDE; B) COLOCACION DEL MEDICAMENTO EN FORMA DE POLVO SUELTO EN EL MOLDE, Y C) EXPANSION DE LOS ELEMENTOS EXPANSIBLES PERPENDICULARMENTE AL EJE LONGITUDINAL DEL MOLDE. TAMBIEN SE DESCRIBEN UN APARATO PARA USO EN EL PROCESO DE ACUERDO DE ACUERDO CON LA INVENCION Y MEDICAMENTOS COMPACTOS FORMADOS POR DICHO PROCESO.
ES93914852T 1992-06-30 1993-06-30 Procedimiento de produccion de formulaciones para medicamentos. Expired - Lifetime ES2110098T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213874A GB9213874D0 (en) 1992-06-30 1992-06-30 Process to novel medicament form

Publications (1)

Publication Number Publication Date
ES2110098T3 true ES2110098T3 (es) 1998-02-01

Family

ID=10717946

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93914852T Expired - Lifetime ES2110098T3 (es) 1992-06-30 1993-06-30 Procedimiento de produccion de formulaciones para medicamentos.

Country Status (11)

Country Link
US (1) US5976436A (es)
EP (1) EP0650410B1 (es)
JP (1) JP3477201B2 (es)
AT (1) ATE160725T1 (es)
CA (1) CA2137826C (es)
DE (1) DE69315578T2 (es)
DK (1) DK0650410T3 (es)
ES (1) ES2110098T3 (es)
GB (1) GB9213874D0 (es)
GR (1) GR3026059T3 (es)
WO (1) WO1994000291A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111194A (en) * 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
DE4436854A1 (de) * 1994-10-15 1996-04-18 Ggu Gesundheits Umweltforsch Arzneistoff-Vorrat zur mechanischen Freisetzung von lungengängigen Wirkstoff-Aerosolen für die inhalative Applikation von Arzneistoffen
US5676967A (en) * 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7134623B2 (en) * 2001-05-17 2006-11-14 Rader Companies Hammermill
CZ20033428A3 (en) * 2001-05-17 2004-05-12 Raderácompanies A hammermill
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
EP1572217B1 (en) 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
DE102004026969A1 (de) * 2004-06-02 2005-12-29 Sms Meer Gmbh Vorrichtung zum Herstellen eines Formteils aus Pulver
CA2575692C (en) 2004-08-20 2014-10-14 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
CA2642641A1 (en) * 2006-02-15 2007-08-23 Tika Laekemedel Ab Stable corticosteroid mixtures
MX2008010721A (es) 2006-02-22 2008-09-01 Mannkind Corp Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
CA2740360A1 (en) * 2008-10-14 2010-04-22 Activaero Gmbh Method for treatment of copd and other pulmonary diseases
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
JP5667095B2 (ja) 2009-03-11 2015-02-12 マンカインド コーポレイション 吸入器の抵抗を測定するための装置、システムおよび方法
KR20180036807A (ko) 2009-06-12 2018-04-09 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
CA2801936C (en) 2010-06-21 2021-06-01 Mannkind Corporation Dry powder drug delivery system and methods
CN103826988B (zh) 2011-04-01 2016-03-09 曼金德公司 用于药物药盒的泡罩包装
US20140113877A1 (en) 2011-06-15 2014-04-24 Takeda Gmbh Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compounds
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112013031791A2 (pt) 2011-06-17 2017-01-31 Takeda Gmbh derivados de ftalazinona-pirrolopirimidinacarboxamida
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX2016000739A (es) 2013-07-18 2017-04-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US950567A (en) * 1908-11-30 1910-03-01 Granville Kesling Pipe and tile mold.
US2312381A (en) * 1940-10-24 1943-03-02 Frank J Bickenheuser Medicinal tablet
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
GB881701A (en) * 1959-09-11 1961-11-08 Ici Ltd Production of hollow articles from polytetrafluoroethylene
FR1346567A (fr) * 1962-12-26 1963-12-20 Asea Ab Appareil à haute pression, notamment pour la transformation du graphite en diamant
US3561079A (en) * 1968-03-11 1971-02-09 Robinson Clay Product Co The Apparatus for pressing of clay pipe using an elastomeric mandrel
US3583200A (en) * 1969-05-19 1971-06-08 Grotnes Machine Works Inc Expanding head and improved seal therefor
US4039703A (en) * 1973-11-13 1977-08-02 Sumitomo Electric Industries, Ltd. Method for producing a tubular multi-layered porous barrier
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
CA2007683A1 (en) * 1989-02-03 1990-08-03 James C. Danly, Sr. Composite and self-lubricating bushing and method for making same
DE69012458T3 (de) * 1989-05-31 2000-01-20 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation

Also Published As

Publication number Publication date
US5976436A (en) 1999-11-02
DE69315578D1 (de) 1998-01-15
GB9213874D0 (en) 1992-08-12
WO1994000291A1 (en) 1994-01-06
CA2137826A1 (en) 1994-01-06
EP0650410A1 (en) 1995-05-03
DK0650410T3 (da) 1998-05-25
CA2137826C (en) 2005-01-25
EP0650410B1 (en) 1997-12-03
GR3026059T3 (en) 1998-05-29
DE69315578T2 (de) 1998-04-02
ATE160725T1 (de) 1997-12-15
JP3477201B2 (ja) 2003-12-10
JPH07508194A (ja) 1995-09-14

Similar Documents

Publication Publication Date Title
ES2110098T3 (es) Procedimiento de produccion de formulaciones para medicamentos.
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
NL7903421A (nl) N-gesubstitueerde moranolinederivaten, werkwijze voor de bereiding van een geneesmiddel daaruit en aldus verkregen geneesmiddel.
NL970031I1 (nl) Werkwijze voor de bereiding van ftalanderivaten enwerkwijze voor de bereiding van farmaceutische pr eparaten die een ftalanderivaat bevatten.
ES469989A1 (es) Un metodo de producir un cuerpo de capsula
NL183032C (nl) Werkwijze ter bereiding van farmaceutisch werkzame n-gesubstitueerde 4,5,6,7-tetrahydrothieno-pyridinederivaten, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en farmaceutisch voorwerp.
PT78434B (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
IL56664A0 (en) New propanone derivatives,process for producing them and pharmaceutical composition containig this derivative as active ingredient
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
DK0725725T3 (da) Fremgangsmåde til fremstilling af lægemiddelformuleringer
ES8103972A1 (es) Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina
FI870808A (fi) 9-alfa, 11-beta-substituerade och 11-beta-substituerade estraner.
NL7608496A (nl) Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7609463A (nl) Werkwijze voor de bereiding van orale antilipe- mische middelen, alsmede aldus verkregen geneesmiddel.
NL7801251A (nl) Werkwijze voor de bereiding van farmacologisch werkzame chinolinen, werkwijze voor de berei- ding van een geneesmiddel en dergelijk genees- middel.
NL184258C (nl) Werkwijze ter bereiding van een farmaceutisch aanvaardbare vorm van het geneesmiddel natrium 7-(d-alfa-formyloxy-alfa-fenylaceetamido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cefem-4-carboxylaat, alsmede werkwijze ter bereiding van een farmaceutisch preparaat.
HU173928B (hu) Sposob poluchenija proizvodnykh sul'foksida s lechebnoj aktivnost'ju
NL7600250A (nl) Werkwijze voor de bereiding van nieuwe verbindin- gen, werkwijze voor de bereiding van farmaceuti- sche preparaten en geneesmiddelen, verkregen met die werkwijze.
NL7613318A (nl) Werkwijze voor de bereiding van nieuwe n-gesubsti- tueerde pyrrolidoncarbonzuren, werkwijze voor de bereiding van therapeutische preparaten die deze nieuwe verbindingen bevatten, alsmede gevormd the- rapeutisch preparaat verkregen volgens deze werkwijze.
DE2961524D1 (en) Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations
NL7607231A (nl) Werkwijze voor de bereiding van een geneesmid- del voor de behandeling van rundermastitis als- mede aldus verkregen geneesmiddel.
JPS51126308A (en) Process for producing a super alloy plate
NL7705664A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel, werkwijze voor de bereiding van een antibiotisch mengsel en een antibioticum en an- tibiotisch mengsel of antibioticum, verkregen volgens deze werkwijze.
NL7809767A (nl) Reeks van kunststof gebonden magneetlichamen, alsmede werkwijze voor de vervaardiging daarvan.
NO174580C (no) Fremgangsmåte og innretning til fremstilling av enbasiske drivladningskrutt med alkohol og eter som opplösningsmiddel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 650410

Country of ref document: ES